Clene (CLNN) insider sale: 3,401 shares at $5.34 reported
Clene Inc. (CLNN) insider sale reported.
Rhea-AI Filing Summary
Clene Inc. (CLNN) insider sale reported. General Resonance LLC reported a sale of 3,401 shares of Clene common stock on 08/21/2025 at a price of $5.34 per share, leaving beneficial ownership of 704,591 shares. The Form 4 was filed by one reporting person and signed by Heidi Ley.
Positive
- None.
Negative
- None.
Insights
TL;DR: Insider reported a routine sale of 3,401 shares; change appears limited in scale relative to total holdings.
The Form 4 discloses a single non-derivative sale of 3,401 shares on 08/21/2025 at $5.34, reducing beneficial ownership to 704,591 shares. The filing is straightforward with no derivative transactions or amendments noted. This appears to be a routine Section 16 disclosure without additional context or plan language disclosed.
TL;DR: Disclosure complies with Section 16; transaction is reported and signed, indicating procedural completeness.
The document identifies General Resonance LLC as the reporting person and indicates the filer is a director and 10% owner. The sale is reported on Form 4 and manually signed. There is no indication of Rule 10b5-1 plan reliance or other arrangements in the provided text.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 3,401 | $5.34 | $18K |
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction was reported for Clene (CLNN)?
When was the Clene (CLNN) insider sale executed?
Who signed the Form 4 for this Clene (CLNN) transaction?
AI-generated analysis. How Rhea-AI works. Not financial advice.